Biomarin Pharmaceutical (BMRN) Com Stk USD0.001
Sell:$54.87Buy:$66.10
$7.22
(10.70%)
NASDAQ:
5.82%
5.82%Market closed | Prices delayed by at least 15 minutes
- This stock can be held in a
Stocks and Shares ISASell:$54.87
Buy:$66.10
Change:$7.22
(10.70%)
$7.22
(10.70%)Market closed | Prices delayed by at least 15 minutes
Sell:$54.87
Buy:$66.10
Change:$7.22
(10.70%)
$7.22
(10.70%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 19 March 2025 | Erin BurkhartChief Accounting Officer | Sell Option/Award related | 1,295 | $71.52 | $92,618.40 | 16,955 |
| 14 March 2025 | Alexander HardyPresident/CEO | Sell Tax related | 2,933 | $69.44 | $203,667.52 | 131,223 |
| 14 March 2025 | Brian R. MuellerCFO | Sell Tax related | 18,497 | $69.44 | $1,284,431.68 | 83,141 |
| 14 March 2025 | George Eric DavisChief Legal/Compliance Officer | Sell Tax related | 16,249 | $69.44 | $1,128,330.56 | 69,975 |
| 14 March 2025 | Charles Greg GuyerCTO | Sell Tax related | 20,127 | $69.44 | $1,397,618.88 | 67,528 |
| 14 March 2025 | Erin BurkhartChief Accounting Officer | Sell Tax related | 823 | $69.44 | $57,149.12 | 12,282 |
| 6 March 2025 | Charles Greg GuyerCTO | Sell Regular sell transaction (market) | 7,034 | $71.28 | $501,355.38 | 87,655 |
| 28 February 2025 | Charles Greg GuyerCTO | Sell Tax related | 4,287 | $71.16 | $305,062.92 | 94,689 |
| 24 February 2025 | Erin BurkhartChief Accounting Officer | Sell Regular sell transaction (market) | 1,344 | $68.38 | $91,902.72 | 13,105 |
| 29 November 2024 | Alexander HardyPresident/CEO | Sell Tax related | 14,295 | $66.03 | $943,898.85 | 134,156 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 28 May 2024 | George Eric DavisChief Legal/Compliance Officer | Sell Option/Award related | 38,071 | $74.46 | $2,834,576.31 | 58,936 |
| 12 April 2024 | Jean Jacques BienaimeChairman/CEO | Sell Option/Award related | 20,000 | $91.26 | $1,825,200.00 | 474,994 |
| 11 April 2024 | Jean Jacques BienaimeChairman/CEO | Sell Option/Award related | 20,000 | $90.99 | $1,819,800.00 | 474,994 |
| 9 May 2024 | Jean Jacques BienaimeChairman/CEO | Sell Option/Award related | 20,000 | $81.62 | $1,632,400.00 | 474,994 |
| 10 May 2024 | Jean Jacques BienaimeChairman/CEO | Sell Option/Award related | 20,000 | $81.14 | $1,622,800.00 | 474,994 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.